These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30945453)

  • 1. Utility of thromboelastography for the diagnosis of von Willebrand disease.
    Regling K; Kakulavarapu S; Thomas R; Hollon W; Chitlur MB
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27714. PubMed ID: 30945453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients.
    Doshi BS; Rogers RS; Whitworth HB; Stabnick EA; Britton J; Butler RB; Obstfeld AE; Witmer CM
    J Thromb Haemost; 2019 Nov; 17(11):1838-1847. PubMed ID: 31350816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
    Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F
    Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).
    Tosetto A; Rodeghiero F; Castaman G; Bernardi M; Bertoncello K; Goodeve A; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Budde U; Ingerslev J; Vorlova Z; Habart D; Holmberg L; Lethagen S; Pasi J; Hill F; Peake I
    J Thromb Haemost; 2007 Apr; 5(4):715-21. PubMed ID: 17408405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin.
    Graf L; Moffat KA; Carlino SA; Chan AK; Iorio A; Giulivi A; Hayward CP
    Int J Lab Hematol; 2014 Jun; 36(3):341-51. PubMed ID: 24750681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system.
    Nogami K; Ogiwara K; Yada K; Shida Y; Takeyama M; Yaoi H; Minami H; Furukawa S; Hosokawa K; Shima M
    J Thromb Haemost; 2016 Apr; 14(4):667-74. PubMed ID: 27061057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease.
    Verfaillie CJ; De Witte E; Devreese KM
    Int J Lab Hematol; 2013 Oct; 35(5):555-65. PubMed ID: 23551532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Utility of Thromboelastography in Monitoring Von Willebrand Disease: A Case Report.
    Al-Jumaili Z; Ibrahim N; Ahmed AA; Chang B; Wahed A; Mai B
    Ann Clin Lab Sci; 2024 Mar; 54(2):246-250. PubMed ID: 38802159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closing the gap - detection of clinically relevant von Willebrand disease in emergency settings through an improved algorithm based on rotational Thromboelastometry.
    Topf HG; Strasser ER; Breuer G; Rascher W; Rauh M; Fahlbusch FB
    BMC Anesthesiol; 2019 Jan; 19(1):10. PubMed ID: 30630422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive re-evaluation of historical von Willebrand disease diagnosis in association with whole blood platelet aggregation and function.
    Nummi V; Lassila R; Joutsi-Korhonen L; Armstrong E; Szanto T
    Int J Lab Hematol; 2018 Jun; 40(3):304-311. PubMed ID: 29427305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
    Favaloro EJ; Mohammed S
    Thromb Res; 2016 May; 141():202-11. PubMed ID: 26743192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms.
    Akin M; Balkan C; Karapinar DY; Kavakli K
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):316-9. PubMed ID: 21949039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of von Willebrand disease in children.
    Sidonio RF; Gunawardena S; Shaw PH; Ragni M
    Pediatr Blood Cancer; 2012 May; 58(5):736-40. PubMed ID: 22237978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
    Nichols WL; Hultin MB; James AH; Manco-Johnson MJ; Montgomery RR; Ortel TL; Rick ME; Sadler JE; Weinstein M; Yawn BP
    Haemophilia; 2008 Mar; 14(2):171-232. PubMed ID: 18315614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease.
    Gill JC; Shapiro A; Valentino LA; Bernstein J; Friedman C; Nichols WL; Manco-Johnson M
    Haemophilia; 2011 Nov; 17(6):895-905. PubMed ID: 21535320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and management of von Willebrand disease].
    Higasa S; Tokugawa T; Sawada A
    Rinsho Ketsueki; 2018; 59(10):2222-2232. PubMed ID: 30305529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.